UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota Journal article
Li, Chenwen, Zhao, Yang, Cheng, Juan, Guo, Jiawei, Zhang, Qixiong, Zhang, Xiangjun, Ren, Jiong, Wang, Fengchao, Huang, Jun, Hu, Houyuan, Wang, Ruibing, Zhang, Jianxiang. A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota[J]. Advanced Science, 2019, 6(18).
Authors:  Li, Chenwen;  Zhao, Yang;  Cheng, Juan;  Guo, Jiawei;  Zhang, Qixiong; et al.
Favorite | TC[WOS]:137 TC[Scopus]:142  IF:14.3/16.3 | Submit date:2020/04/02
Colitis Targeting  Gut Microbiota  Nanotherapy  Proresolving Peptide  Reactive Oxygen Species  
Structure-property correlations of reactive oxygen species-responsive and hydrogen peroxide-eliminating materials with anti-oxidant and anti-inflammatory activities Journal article
Zhang,Qixiong, Zhang,Fuzhong, Chen,Yue, Dou,Yin, Tao,Hui, Zhang,Dinglin, Wang,Ruibing, Li,Xiaohui, Zhang,Jianxiang. Structure-property correlations of reactive oxygen species-responsive and hydrogen peroxide-eliminating materials with anti-oxidant and anti-inflammatory activities[J]. Chemistry of Materials, 2017, 29(19), 8221-8238.
Authors:  Zhang,Qixiong;  Zhang,Fuzhong;  Chen,Yue;  Dou,Yin;  Tao,Hui; et al.
Favorite | TC[WOS]:98 TC[Scopus]:102  IF:7.2/8.4 | Submit date:2021/03/02
A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease Journal article
Qixiong Zhang, Hui Tao, Yongyao Lin, Ying Hu, Huijie An, Dinglin Zhang, Shibin Feng, Houyuan Hu, Ruibing Wang, Xiaohui Li, Jianxiang Zhang. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease[J]. Biomaterials, 2016, 105, 206-221.
Authors:  Qixiong Zhang;  Hui Tao;  Yongyao Lin;  Ying Hu;  Huijie An; et al.
Favorite | TC[WOS]:179 TC[Scopus]:184  IF:12.8/13.1 | Submit date:2018/11/06
Colitis  Cyclodextrin  Drug Delivery  Reactive Oxygen Species  Responsive Nanoparticles  Targeted Therapy